Gail Friedt
About Gail Friedt
Gail Friedt is a seasoned professional in Medical Affairs, currently serving as a Senior Medical Science Liaison at EUSA Pharma and working in Medical Affairs at DURECT Corporation. With extensive experience in nephrology, critical care, and solid organ transplant, Friedt has held various roles in the pharmaceutical industry since the late 1990s.
Work at DURECT Corporation
Gail Friedt has been working at DURECT Corporation in the Medical Affairs department since 2021. In this role, she applies her extensive knowledge in medical science to support the company's objectives. Her responsibilities include collaborating with key opinion leaders and engaging in various therapeutic areas. Friedt's experience in medical science liaison roles enhances her contributions to DURECT, where she focuses on effective communication of complex medical information.
Current Role at EUSA Pharma
Since 2020, Gail Friedt has served as a Senior Medical Science Liaison at EUSA Pharma in San Diego, California. In this position, she leverages her clinical expertise to facilitate communication between the company and healthcare professionals. Friedt's role involves educating stakeholders about pharmaceutical products and supporting clinical trial initiatives, which aligns with her background in medical affairs.
Education and Expertise
Gail Friedt holds a Master of Science in Nursing (MSN) from California State University-Dominguez Hills, which she completed from 2003 to 2005. She also studied Nursing at the University of North Dakota, earning a Bachelor of Science in Nursing (BSN) from 1980 to 1985. Additionally, she is pursuing a mini-MBA at Loyola University of Chicago, which she began in 2011. Friedt's educational background supports her expertise in nephrology, critical care, solid organ transplant, and immunology.
Professional Background
Gail Friedt has a diverse professional background, having worked in various roles across the pharmaceutical and healthcare industries. Her career includes positions at Stemline Therapeutics, La Jolla Pharmaceutical Company, Abbott Laboratories, Raptor Pharmaceuticals, Sanofi (Genzyme), and PAREXEL. Friedt's experience spans over two decades, with roles ranging from Clinical Research Associate to Medical Science Liaison, showcasing her comprehensive understanding of clinical trials and patient advocacy.
Clinical Trial Contributions
Gail Friedt has utilized innovative strategies to enhance patient accrual in clinical trials. She has extensive experience managing all phases of investigator-initiated trials, including securing funding. Notably, she contributed to a Phase 2b trial evaluating the safety and efficacy of Larsucosterol treatment for alcohol-associated hepatitis. Her involvement in clinical research underscores her commitment to advancing medical knowledge and improving patient outcomes.